Change search criteria ↓

Search results

2 projects found matching your search criteria:

  1. 1. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ7

  2. 2. Novel dual CYP17A1 and AKR1C3 inhibitors for studying the mechanism of resistance in prostate cancer

    Principal investigator: dr hab. Tomasz Marcin Wróbel

    Uniwersytet Medyczny w Lublinie

    Call: SONATA 16, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski